Please Wait
Applying Filters...
Menu
$ API Ref.Price (USD/KG) : 2,116Xls
Filters Filter
Cross PopUp
FILTER :

filter clear-filterReset all filters

01 5Latuda

PharmaCompass

01

Brand Name : Latuda

Lurasidone

arrow
Pharma Manufacturing 2024
Not Confirmed

Brand Name : Latuda

arrow
Pharma Manufacturing 2024
Not Confirmed

Lurasidone

Main Therapeutic Indication : CNS & Anesthesia

Currency : USD

2020 Revenue in Millions : 2,019

2019 Revenue in Millions : 1,802

Growth (%) : 12

blank

02

Brand Name : Latuda

Lurasidone

arrow
Pharma Manufacturing 2024
Not Confirmed

Brand Name : Latuda

arrow
Pharma Manufacturing 2024
Not Confirmed

Lurasidone

Main Therapeutic Indication : Neurology

Currency : USD

2021 Revenue in Millions : 1,764

2020 Revenue in Millions : 2,019

Growth (%) : 0

blank

03

Brand Name : Latuda

Lurasidone

arrow
Pharma Manufacturing 2024
Not Confirmed

Brand Name : Latuda

arrow
Pharma Manufacturing 2024
Not Confirmed

Lurasidone

Main Therapeutic Indication : Neurology

Currency : USD

2022 Revenue in Millions : 1,811

2021 Revenue in Millions : 1,764

Growth (%) : 3

blank

04

Brand Name : Latuda

Lurasidone Hydrochloride

arrow
Pharma Manufacturing 2024
Not Confirmed

Brand Name : Latuda

arrow
Pharma Manufacturing 2024
Not Confirmed

Lurasidone Hydrochloride

Main Therapeutic Indication : Neurology

Currency : USD

2023 Revenue in Millions : 264

2022 Revenue in Millions : 3,019

Growth (%) : -90

blank

05

Brand Name : Latuda

Lurasidone

arrow
Pharma Manufacturing 2024
Not Confirmed

Brand Name : Latuda

arrow
Pharma Manufacturing 2024
Not Confirmed

Lurasidone

Main Therapeutic Indication : CNS & Anesthesia

Currency : USD

2019 Revenue in Millions : 1,739

2018 Revenue in Millions : 1,703

Growth (%) : 2

blank